Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment

Robin Forrest, Mylene Lagarde, Ajay Aggarwal, Huseyin Naci

Open source

DOI
10.1016/s1470-2045(24)00596-5
Published
2024-12
Container
The Lancet Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00596-5,
  title = {Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment},
  author = {Robin Forrest and Mylene Lagarde and Ajay Aggarwal and Huseyin Naci},
  year = {2024},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(24)00596-5},
  url = {https://doi.org/10.1016/s1470-2045(24)00596-5}
}

RIS

TY  - JOUR
TI  - Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment
AU  - Robin Forrest
AU  - Mylene Lagarde
AU  - Ajay Aggarwal
AU  - Huseyin Naci
PY  - 2024
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(24)00596-5
UR  - https://doi.org/10.1016/s1470-2045(24)00596-5
ER  - 

APA

Forrest, R., Lagarde, M., Aggarwal, A., & Naci, H. (2024). Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(24)00596-5

Source records